These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37738970)

  • 1. SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
    Bouhaddou M; Reuschl AK; Polacco BJ; Thorne LG; Ummadi MR; Ye C; Rosales R; Pelin A; Batra J; Jang GM; Xu J; Moen JM; Richards AL; Zhou Y; Harjai B; Stevenson E; Rojc A; Ragazzini R; Whelan MVX; Furnon W; De Lorenzo G; Cowton V; Syed AM; Ciling A; Deutsch N; Pirak D; Dowgier G; Mesner D; Turner JL; McGovern BL; Rodriguez ML; Leiva-Rebollo R; Dunham AS; Zhong X; Eckhardt M; Fossati A; Liotta NF; Kehrer T; Cupic A; Rutkowska M; Mena I; Aslam S; Hoffert A; Foussard H; Olwal CO; Huang W; Zwaka T; Pham J; Lyons M; Donohue L; Griffin A; Nugent R; Holden K; Deans R; Aviles P; Lopez-Martin JA; Jimeno JM; Obernier K; Fabius JM; Soucheray M; Hüttenhain R; Jungreis I; Kellis M; Echeverria I; Verba K; Bonfanti P; Beltrao P; Sharan R; Doudna JA; Martinez-Sobrido L; Patel AH; Palmarini M; Miorin L; White K; Swaney DL; Garcia-Sastre A; Jolly C; Zuliani-Alvarez L; Towers GJ; Krogan NJ
    Cell; 2023 Oct; 186(21):4597-4614.e26. PubMed ID: 37738970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of enhanced innate immune evasion by SARS-CoV-2.
    Thorne LG; Bouhaddou M; Reuschl AK; Zuliani-Alvarez L; Polacco B; Pelin A; Batra J; Whelan MVX; Hosmillo M; Fossati A; Ragazzini R; Jungreis I; Ummadi M; Rojc A; Turner J; Bischof ML; Obernier K; Braberg H; Soucheray M; Richards A; Chen KH; Harjai B; Memon D; Hiatt J; Rosales R; McGovern BL; Jahun A; Fabius JM; White K; Goodfellow IG; Takeuchi Y; Bonfanti P; Shokat K; Jura N; Verba K; Noursadeghi M; Beltrao P; Kellis M; Swaney DL; García-Sastre A; Jolly C; Towers GJ; Krogan NJ
    Nature; 2022 Feb; 602(7897):487-495. PubMed ID: 34942634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants.
    Reuschl AK; Thorne LG; Whelan MVX; Ragazzini R; Furnon W; Cowton VM; De Lorenzo G; Mesner D; Turner JLE; Dowgier G; Bogoda N; Bonfanti P; Palmarini M; Patel AH; Jolly C; Towers GJ
    Nat Microbiol; 2024 Feb; 9(2):451-463. PubMed ID: 38228858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.
    Essink BJ; Shapiro C; Isidro MGD; Bradley P; Pragalos A; Bloch M; Santiaguel J; Frias MV; Miyakis S; Alves de Mesquita M; Berrè S; Servais C; Waugh N; Hoffmann C; Baba E; Schönborn-Kellenberger O; Wolz OO; Koch SD; Ganyani T; Boutet P; Mann P; Mueller SO; Ramanathan R; Gaudinski MR; Vanhoutte N
    Hum Vaccin Immunother; 2024 Dec; 20(1):2408863. PubMed ID: 39422261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning.
    Meehan GR; Herder V; Allan J; Huang X; Kerr K; Mendonca DC; Ilia G; Wright DW; Nomikou K; Gu Q; Molina Arias S; Hansmann F; Hardas A; Attipa C; De Lorenzo G; Cowton V; Upfold N; Palmalux N; Brown JC; Barclay WS; Filipe ADS; Furnon W; Patel AH; Palmarini M
    PLoS Pathog; 2023 Nov; 19(11):e1011589. PubMed ID: 37934791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations make pandemics worse or better: modeling SARS-CoV-2 variants and imperfect vaccination.
    Bugalia S; Tripathi JP; Wang H
    J Math Biol; 2024 Mar; 88(4):45. PubMed ID: 38507066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host immune responses associated with SARS-CoV-2 Omicron infection result in protection or pathology during reinfection depending on mouse genetic background.
    Singh G; Warang P; García-Bernalt Diego J; Chang L; Bykov Y; Singh S; Pache L; Cuadrado-Castano S; Webb B; Garcia-Sastre A; Schotsaert M
    Res Sq; 2023 Nov; ():. PubMed ID: 38077015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Timing and Magnitude of the Type I Interferon Response Are Correlated with Disease Tolerance in Arbovirus Infection.
    Hardy A; Bakshi S; Furnon W; MacLean O; Gu Q; Varjak M; Varela M; Aziz MA; Shaw AE; Pinto RM; Cameron Ruiz N; Mullan C; Taggart AE; Da Silva Filipe A; Randall RE; Wilson SJ; Stewart ME; Palmarini M
    mBio; 2023 Jun; 14(3):e0010123. PubMed ID: 37097030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benchmark Investigation of SARS-CoV-2 Mutants' Immune Escape with 2B04 Murine Antibody: A Step Towards Unraveling a Larger Picture.
    Kapusta K; McGowan A; Banerjee S; Wang J; Kolodziejczyk W; Leszczynski J
    Curr Issues Mol Biol; 2024 Nov; 46(11):12550-12573. PubMed ID: 39590339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.
    Russell TW; Townsley H; Abbott S; Hellewell J; Carr EJ; Chapman LAC; Pung R; Quilty BJ; Hodgson D; Fowler AS; Adams L; Bailey C; Mears HV; Harvey R; Clayton B; O'Reilly N; Ngai Y; Nicod J; Gamblin S; Williams B; Gandhi S; Swanton C; Beale R; Bauer DLV; Wall EC; Kucharski AJ
    PLoS Biol; 2024 Jan; 22(1):e3002463. PubMed ID: 38289907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.
    Tramacere I; Virgili G; Perduca V; Lucenteforte E; Benedetti MD; Capobussi M; Castellini G; Frau S; Gonzalez-Lorenzo M; Featherstone R; Filippini G
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012186. PubMed ID: 38032059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT.
    Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D
    Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Activation Syndrome in Coinciding Pandemics of Obesity and COVID-19: Worse than Bad.
    Engin AB; Engin ED; Engin A
    Adv Exp Med Biol; 2024; 1460():919-954. PubMed ID: 39287877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatiotemporal evolution and transmission dynamics of Alpha and Delta SARS-CoV-2 variants contributing to sequential outbreaks in Cambodia during 2021.
    Su YCF; Zeller MA; Ou TP; Ma J; Pum L; Zhang R; Rath S; Heang V; Kol S; Lim R; Chea KL; Khun L; Heng L; Krang S; Raftery P; Kinzer MH; Ieng V; Kab V; Patel S; Sar B; Horm VS; Yann S; Auerswald H; Siegers JY; Troupin C; Boukli N; Vandelannoote K; Wong FY; Ng GGK; Chan M; Sorn S; Sengdoeurn Y; Heng S; Darapheak C; Savuth C; Khalakdina A; Ly S; Baril L; Spiegel A; Duong V; Ly S; Smith GJD; Karlsson EA
    Commun Med (Lond); 2024 Nov; 4(1):252. PubMed ID: 39604601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch).
    Geismar C; Nguyen V; Fragaszy E; Shrotri M; Navaratnam AMD; Beale S; Byrne TE; Fong WLE; Yavlinsky A; Kovar J; Braithwaite I; Aldridge RW; Hayward AC; White P; Jombart T; Cori A
    Lancet; 2022 Nov; 400 Suppl 1():S40. PubMed ID: 36929985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.
    Kakizaki M; Hashimoto R; Nagata N; Yamamoto T; Okura T; Katoh H; Kitai Y; Akahori Y; Shirato K; Ryo A; Takayama K; Takeda M
    J Virol; 2024 Nov; ():e0185324. PubMed ID: 39601592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.
    Deng L; Dai P; Ding W; Granstein RD; Shuman S
    J Virol; 2006 Oct; 80(20):9977-87. PubMed ID: 17005676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Field Theory of Executive Function: Identifying Early Neurocognitive Markers.
    McCraw A; Sullivan J; Lowery K; Eddings R; Heim HR; Buss AT
    Monogr Soc Res Child Dev; 2024 Dec; 89(3):7-109. PubMed ID: 39628288
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.